Skip to main content
. 2015 Oct 18;2015:607364. doi: 10.1155/2015/607364

Table 1.

General characteristics of the study participants according to presence or absence of MetS.

Parameters Men (n = 768) Women (n = 860)
Without MetS
(n = 504)
With MetS
(n = 264)
p Without MetS
(n = 593)
With MetS
(n = 267)
p
Anthropometric characteristics
 Age (y) 44.44 ± 13.98 50.34 ± 11.47 <0.01 40.17 ± 12.25 49.38 ± 11.48 <0.01
 Waist circumference (cm) 83.07 ± 9.31 99.14 ± 8.17 <0.01 77.46 ± 9.67 91.52 ± 8.27 <0.01
 BMI (kg/m2) 23.10 ± 3.09 28.60 ± 3.37 <0.01 22.60 ± 3.43 27.39 ± 3.65 <0.01
 Systolic BP (mmHg) 126.80 ± 21.61 144.60 ± 20.34 <0.01 122.60 ± 19.89 144.73 ± 25.60 <0.01
 Diastolic BP (mmHg) 81.59 ± 13.33 92.39 ± 12.12 <0.01 78.72 ± 12.26 92.03 ± 12.85 <0.01
 Current smoker (n [%]) 258 (51.29%) 214 (81.06%) <0.01 231 (38.89%) 214 (80.15%) <0.01
Metabolic characteristics
 Total cholesterol (mmol/L) 4.14 ± 0.98 4.75 ± 1.23 <0.01 4.13 ± 1.08 4.57 ± 1.28 <0.01
 TG (mmol/L) 1.01 ± 0.48 2.06 ± 1.30 <0.01 0.93 ± 0.42 1.55 ± 0.87 <0.01
 HDL cholesterol (mmol/L) 1.42 ± 0.42 1.38 ± 0.57 <0.01 1.60 ± 0.43 1.31 ± 0.49 <0.01
 LDL cholesterol (mmol/L) 2.19 ± 0.69 2.53 ± 0.97 <0.01 2.05 ± 0.69 2.49 ± 0.82 <0.01
 FBG (mmol/L) 4.47 ± 0.93 5.57 ± 1.47 <0.01 4.28 ± 0.79 5.19 ± 1.22 <0.01
 Insulin (μIU/dL) 10.80 (7.01–14.72) 14.95 (12.30–17.00) <0.01 9.60 (7.20–15.50) 14.61 (8.40–17.50) <0.01
 HOMA-IR 2.05 (1.32–3.00) 3.31 (2.47–4.54) <0.01 1.81 (1.37–3.08) 3.28 (1.77–4.31) <0.01
 Adiponectin (µg/mL) 5.78 (4.18–6.63) 4.04 (2.67–5.65) <0.01 6.98 (5.43–8.40) 5.70 (3.93–8.12) <0.05
 A/H ratio 2.43 (1.50–3.95) 1.08 (0.75–1.91) <0.01 3.30 (2.08–5.00) 2.02 (1.00–3.57) <0.01
 IL-6 (pg/mL) 0.65 (0.16–1.39) 1.58 (1.18–1.97) <0.01 0.53 (0.15–1.33) 1.60 (0.99–2.01) <0.01

Values are expressed as means ± SD or number (%), if not stated otherwise. Median values of adiponectin, fasting insulin, IL-6, and HOMA-IR are presented (lower quartile-upper quartile).

SD, standard deviation; BMI, body mass index; TG, triglyceride; BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; FBG, fasting blood glucose; HOMA-IR, homeostasis model assessment of insulin resistance; IL-6, interleukin-6; A/H ratio, adiponectin to homeostasis assessment-insulin resistance.